-
The King Tides Project kicks off this weekend. How you can help - 2 mins ago
-
Pirate From Minnesota Jailed Over Kidnap of Journalist - 8 mins ago
-
Matthew Nicholson throws down a two-handed slam to help Northwestern lead over UIC going into the half - 11 mins ago
-
Fight against Climate Change Should Not Put Farmers at a Disadvantage - 19 mins ago
-
Deputy PM: Trump’s presidency is beacon of hope for Europe and Hungary - 30 mins ago
-
American live-streamer gets travel ban for causing ‘commotion’ - 35 mins ago
-
Construction worker convicted of murdering elderly Arcadia woman - 42 mins ago
-
Tears as ‘Overlooked’ Senior Shelter Dog Watches On As Others Get Adopted - 50 mins ago
-
Green Light for Auchan Hungary Acquisition, Boosting Local Ownership - 52 mins ago
-
Deion Sanders compares Shedeur and Travis’ chemistry to Michael Irvin and Troy Aikman | Speak - 55 mins ago
Billions for Hungarian biotech company
The Spanish diagnostics group Werfen is acquiring the Hungarian company Omixon for around 25 million US dollars.
The Barcelona-based group has finalised the acquisition of the Hungarian company Omixon after receiving all the necessary regulatory approvals, reported the Hungarian edition of the business magazine Forbes. Omixon Biocomputing Kft. was founded in 2011 by Attila Bérces and has developed from a software developer for genetics into a specialist for sequencing technologies (NGS) used in transplant diagnostics.
Renowned investors
Several venture capitalists were involved in financing the company, including Fastventures Zrt. and Lochlomond Holding as well as Euroventures. Márton Szőke has already helped several Hungarian start-ups to success as an investor. He was involved in Tresorit, which Swiss Post acquired three years ago for 47 million Swiss francs, and has recently invested in Bitrise and Recart.
Strong growth during corona
The company recorded strong growth in 2020 thanks to the development of a novel coronavirus test. The viral RNA detection directly from the heat-treated sample made the test faster and more efficient. In 2020, the company generated 35-40% of its turnover of 2.5 billion forints with this test, compared to 1.6 billion forints in 2023. For founder Attila Bérces, the merger with Werfen marks an exciting new chapter in strengthening the company’s global presence. The buyer Werfen, with technology centres in the USA and Europe, has an annual turnover of over 2 billion US dollars and employs more than 5,000 people.
Source link